Exposure to Wildfire Smoke Greatly Raises Risk of Dementia
Wildfire smoke may be particularly hazardous to brain health, according to a 10-year study of more than 1.2 million southern Californians.
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.
Wildfire smoke may be particularly hazardous to brain health, according to a 10-year study of more than 1.2 million southern Californians.
Research reported at AAIC shows blood tests can be 90% accurate in diagnosing Alzheimer’s disease and could be use in primary care and memory clinics.
Special ISTAART Research Retrospectives interview with Professor Bruce Miller discussing his research & his seminal papers on Frontotemporal dementia
Special ISTAART Research Retrospectives interview with Professor Alison Goate discussing her research & her seminal papers on the amyloid precursor protein gene
Join Alzheimer’s Association with Dr Rebecca Edelmayer & Dr Percy Griffin for a discussion about recent advancements in Alzheimer’s research.
ISTAART is delighted to announce that 15 Professional Interest Areas (PIAs) are hosting Year in Review webinars during January 2024 – Have your Say and Register
The ISTAART PIA to Elevate Early Career Researchers is planning for 2024 and is looking for ECR volunteers to join their six continent working groups.
Register to attend your ISTAART Professional Interest Areas annual ‘All Members Meeting’ (formerly known as Business Meetings) during September 2023.
Volunteering in late life is associated with better cognitive function, better executive function & episodic memory, according to research presented at the AAIC
Experiencing less frequent bowel movements is associated with cognitive decline, according to new research reported today at the AAIC
Research reported at AAIC shows a simple, finger prick blood test shows promise in the ability to detect Alzheimer’s disease.
New Research from AAIC reports on the largest clinical trial to investigate whether a hearing loss treatment intervention can reduce risk of cognitive decline.